Source: Seeking Alpha
Pfizer Inc. (NYSE:PFE)
Q2 2014 Earnings Conference Call
July 29, 2014 10:00 AM ET
Executives
Chuck Triano – SVP of IR
Ian Read – Chairman and CEO
Frank D’Amelio – CFO
Mikael Dolsten – President of Worldwide Research and Development
Albert Bourla – President of Vaccines, Oncology and Consumer
Geno Germano – President of Global Innovative Pharma
John Young – President of Established Pharma
Doug Lankler – General Counsel
Analysts
Chris Schott – JPMorgan
Vamil Divan – Credit Suisse
Tim Anderson – Sanford Bernstein
Jami Rubin – Goldman Sachs
John Boris – SunTrust Robinson
David Risinger – Morgan Stanley
Colin Bristow – Bank of America
Marc Goodman – UBS
Seamus Fernandez – Leerink
Jeff Holford – Jefferies
Alex Arfaei – BMO Capital Markets
Andrew Baum – Citi
Mark Schoenebaum – ISI Group
Steve Scala – Cowen
Operator
Good day, everyone and welcome to Pfizer’s Second Quarter 2014 Earnings Conference Call. Today’s call is being recorded. At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead, sir.
Chuck Triano
Thank you, operator. Good morning and thank you for joining us today to review Pfizer’s second quarter 2014 performance. I am joined today in by our Chairman and CEO, Ian Read; Frank D’Amelio, our CFO; Mikael Dolsten, President of Worldwide Research and Development; Albert Bourla, President of Vaccines, Oncology and Consumer; Geno Germano, President of Global Innovative Pharma; John Young, President of Established Pharma and Doug Lankler, General Counsel.
The slides that will be presented on the call can be viewed at pfizer.com, by clicking on the link for Pfizer Quarterly Corporate Performance Second Quarter 2014, which located in the Investor Presentations section in the lower right hand corner of this page.
Pages: First |1 | ... | Next → | Last | View Full Transcript